IMBiologics아이엠바이오로직스
493280 · KOSDAQ · ₩493280 · 아이엠바이오로직스
₩13,800▼ ₩430 (3.02%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| 2025 | |
|---|---|
| Revenue | ₩12B |
| Cost of sales | ₩11B |
| Gross profit | ₩298M |
| Operating income | ₩298M |
| Net income | ₩877M |
| Net income to shareholders | ₩877M |
Balance sheet
| 2025 | |
|---|---|
| Total assets | ₩75B |
| Current assets | ₩74B |
| Cash and equivalents | ₩8.2B |
| Total liabilities | ₩1.8B |
| Current liabilities | ₩1B |
| Borrowings | ₩950M |
| Total equity | ₩73B |
| Shareholders' equity | ₩73B |
Cash flow
| 2025 | |
|---|---|
| Cash from operations | ₩393M |
| Capital spending | ₩502M |
| Free cash flow | −₩110M |
Consolidated where available. Amounts in won.
Also known as: IMBiologics / 아이엠바이오로직스 / 493280 / KRX:493280
Source: KRX statistical information